DIRECTIONS TO RATHMANN AUDITORIUM L O T 9

12 P 402 451

Phelps Hall 570 489 M Campbell esa 11 R Hall o a 101 P d

Engineering 217 Elings Science Henley 10 Hall Buchanan PSB Chemistry 1179 Gate Ellison Hall Hall North P Engineering Ward II Memorial Campus Green Blvd. Kohn PSB Hall South 615 Davidson MRL Library 406 Broida Hall Harold Frank Lagoon Road Hall Webb Hall Bren Hall 1 P N 7 Noble Hall 3 P P Life Pacific Ocean Sciences Bio Psych II

UCEN Road 9 P

UC Santa Barbara

UNIVERSITY OF CALIFORNIA JAMEY MARTH joined the Department of Molecular, Cellular SANTA BARBARA and Developmental Biology and the Biomolecular Science and Engineering Program at UC Santa Barbara in July 2009. He holds a joint appointment with the Sanford-Burnham Medical CHANCELLOR HENRY T. YANG Research Institute and is the Director of The UC Santa Barbara Sanford-Burnham Center for Nanomedicine. Dr. Marth’s cordially invites you to attend the inaugural lecture training and expertise are multi-disciplinary encompassing and reception celebrating the appointment of genetics, , biochemistry, immunology, hematology, developmental biology, infectious disease, and glycobiology. His laboratory is known for having DR. JAMEY MARTH developed Cre-loxP conditional mutagenesis, a technique used worldwide to study Professor of Molecular, Cellular, and Developmental Biology biology and disease, and for elucidating mechanisms of autoimmune disease, Type 2 , and infectious disease. His laboratory is incorporating nanotechnologies TO THE including microfluidic, and microarray platforms to expand basic biological research John Chair in Biochemistry and capabilities and further identify the origins of disease. His laboratory has discovered disease biomarkers and causes for which no diagnostics or therapeutics presently AND HONORING THE DONORS exist. With the Center for Nanomedicine, Dr. Marth is collaborating with both The Amgen Foundation institutions in areas of basic discovery research, as well as the development of William K. Bowes Jr. improved early disease diagnostics, and the design of more effective therapeutics to achieve prevention, treatment, and cure. Dr. Marth is also co-founder and the Chair Franklin “Pitch” Johnson Jr. of the Scientific Advisory Board of Abaron Biosciences, Inc., an early-stage company The Rathmann Family Foundation that is focused on developing a new class of therapeutics for the prevention and treatment of grievous disease. Dr. Marth studied in the laboratories of Dr. Roger M. Friday, May 21, 2010 Perlmutter, now Executive Vice-President of Research and Development at Amgen; 4 p. m. and Dr. Edwin G. Krebs, a 1992 Nobel laureate in Physiology or Medicine. In 1995, Dr. Marth was recruited to UC San Diego by Dr. George Palade – a 1974 Nobel laureate Rathmann Auditorium in Physiology or Medicine, where Dr. Marth was an Investigator of the Howard Hughes Medical Institute and Professor in the Department of Cellular and Molecular Medicine Life Sciences Building prior to his current positions. Dr. Marth received a Ph.D. in Pharmacology from the , Santa Barbara in Seattle. PRESENTATION THE JOHN CARBON CHAIR in Biochemistry and Molecular Biology was generously Nanomedicine: Opportunities in Scientific Discovery established by the Amgen Foundation and several aligned individuals who were all and Disease Treatment key in the founding and success of Amgen: Bill Bowes, Pitch Johnson, and George Rathmann. The Chair honors UCSB Professor of Biochemistry and Molecular Biology, FOLLOWED BY RECEPTION IN COURTYARD John Carbon, and his seminal contributions to science and UCSB. Amgen and UCSB have mutually benefited from a long partnership that began with John Carbon’s role RSVP by Friday, May 14, 2010 (805)893-5819 as a member of Amgen’s original Scientific Advisory Board. The inaugural celebration [email protected] of the appointment of Dr. Jamey Marth as the John Carbon Professor of Biochemistry and Molecular Biology at UC Santa Barbara honors and continues this historic Parking in Lot 9 collaboration. Map on reverse Please advise of special needs